References
Agaimy A, Nose V, Sobrinho-Simoes M. WHO Classification of Tumours Editorial Board. Thyroblastoma. WHO Classification of Endocrine and Neuroendocrine Tumours. Lyon, France: International Agency for Research on Cancer; 2022.
Baloch ZW, Asa SL, Barletta JA, et al (2022) Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol 33:27-63.
Guilmette J, Dias-Santagata D, Lennerz J, et al (2022) Primary thyroid neoplasm with fetal morphology associated with DICER1 mutations: expanding the diagnostic profile of thyroblastoma. Thyroid 32:1423-1428.
Agaimy A, Witkowski L, Stoehr R, et al (2020) Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations–is the term "thyroblastoma" more appropriate? Virchows Arch 477:787-798.
Rooper LM, Bynum JP, Miller KP, et al (2020) Recurrent DICER1 hotspot mutations in malignant thyroid gland teratomas: molecular characterization and proposal for a separate classification. Am J Surg Pathol 44:826-833.
Author information
Authors and Affiliations
Contributions
All of the authors discussed, reviewed, and edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Erickson, L.A., Rivera, M., Guo, R. et al. Thyroblastoma—a Primitive Multilineage Thyroid Neoplasm with Somatic DICER1 Alteration. Endocr Pathol 34, 159–160 (2023). https://doi.org/10.1007/s12022-023-09750-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-023-09750-8